In severe, uncontrolled asthma, tezepelumab reduced exacerbations and improved asthma control at 1 y
- 1 October 2021
- journal article
- editorial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (10), JC115
- https://doi.org/10.7326/acpj202110190-115
Abstract
Source Citation Menzies-Gow A, Corren J, Bourdin A, et al. Tezepelumab in adults and adolescents with severe, uncontrolled asthma. N Engl J Med. 2021;384:1800-9. 33979488 Clinical Impact Ratings GIM/FP/GP: 6 out of 7 Pulmonology: 6 out of 7This publication has 2 references indexed in Scilit:
- Management of severe asthma: a European Respiratory Society/American Thoracic Society guidelineEuropean Respiratory Journal, 2019
- Tezepelumab in Adults with Uncontrolled AsthmaThe New England Journal of Medicine, 2019